Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata in infants may be more common than previously thought.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Some alternative treatments for hair loss might work, but more research is needed.

New lipid nanoparticles show promise for delivering hair loss treatments but need improvement for better skin penetration.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Rose stem cell exosomes can significantly improve hair growth in androgenetic alopecia.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

In the Jazan region of Saudi Arabia, hair loss is common, especially among women, older people, and those with higher education and BMI. Stress, poor nutrition, and hormonal changes are key causes, but many don't seek medical help.

Oral alitretinoin can quickly regrow hair in alopecia universalis.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

PRP treatment effectively improves hair density and thickness in people with androgenic alopecia.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.